Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Dave Singh
Sign up to set email alerts
27
Publications
10
Citation Statements Received
158
Citation Statements Given
How they've been cited
21
2
8
0
How they cite others
128
27
129
2
Affiliations
Manchester University NHS Foundation Trust
,
Medicines Evaluation Unit
Publications
Order By: Most citations
The relationship between eosinophils and reduction in major adverse cardiac events in ETHOS
Bafadhel
1
,
Rabe
2
,
Singh
3
et al.
2021
5
2
4
0
Get access via publisher
Add to collection
Cite
"A" and "V" phenomena.
Singh
1
,
Singh
2
,
Aggarwal
3
et al.
1966
British Journal of Ophthalmology
Abstract
Show
2
0
2
0
Get access via publisher
Add to collection
Cite
The effect of inhaler prescription on the development of lung cancer in COPD: a nationwide population-based study
Park
1
,
Lee
2
,
Singh
3
et al.
2024
Respir Res
Abstract
Show
5
0
1
0
Get access via publisher
Add to collection
Cite
Late Breaking Abstract - A novel macrolide, EP395, in patients with stable COPD: a RCT
Watz
1
,
Korn
2
,
Kornmann
3
et al.
2024
1
0
1
0
Get access via publisher
Add to collection
Cite
Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial
Ferguson
1
,
Singh
2
,
Rabe
3
et al.
2021
0
0
0
0
Get access via publisher
Add to collection
Cite
Effect of Tezepelumab on Lung Function in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease Grouped by Baseline Blood Eosinophil Count: Results From the Phase 2a COURSE Study
Singh
1
,
Rabe
2
,
Han
3
et al.
2025
Abstract
Show
1
0
0
0
Get access via publisher
Add to collection
Cite
Efficacy and Safety of Dupilumab in Patients With Moderate-to-Severe COPD and Type 2 Inflammation: Phase 3 NOTUS Trial
Bhatt
1
,
Rabe
2
,
Hanania
3
et al.
2024
0
0
0
0
Get access via publisher
Add to collection
Cite
Short-acting β
2
-agonist use, exacerbation risk and triple therapy in COPD:
post hoc
analyses of ETHOS
Hurst
1
,
Singh
2
,
Martinez
3
et al.
2025
ERJ Open Res
Abstract
Show
0
0
0
0
Get access via publisher
Add to collection
Cite
1
2
3